Prime Medicine Prices Public Offering At $3.30 Per Share
ReutersJul 31, 2025 1:34 AM
July 30 (Reuters) - Prime Medicine Inc PRME.O:
PRIME MEDICINE ANNOUNCES PRICING OF PUBLIC OFFERING
PRIME MEDICINE INC - PRICES PUBLIC OFFERING AT $3.30 PER SHARE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
What to Expect From Microsoft Q4 FY2025 Earnings: The King of AI Monetization — A $4 Trillion Market Cap Within Reach?
TradingKey - Cloud giant Microsoft (MSFT.US) will report its fiscal fourth-quarter 2025 earnings (calendar Q2) after the U.S. market close on July 30. Wall Street is bullish, expecting strong results from Azure cloud services and AI-driven growth to propel Microsoft’s market capitalization towardTradingKey
Wed, Jul 30
U.S. GDP, PCE, and Fed Rate Decision Preview: U.S. Stocks May Continue to Rise
TradingKey - The United States is set to release its latest GDP and PCE data on 30–31 July 2025, with the Federal Reserve’s interest rate decision expected concurrently. Market consensus anticipates that the annualized real GDP growth rate for the second quarter will turn positiveTradingKey
Tue, Jul 29
What to Expect From Meta Q2 Earnings: AI Push, Ad Strength — But Can Profitability Hold?
TradingKey - Meta Platforms (META), the parent company of Facebook, Instagram, and WhatsApp, will release its Q2 2025 earnings after the U.S. market close on Wednesday, July 30. After nine consecutive quarters of beating expectations, analysts expect another strong performance — driven by AI-poweredTradingKey
Tue, Jul 29
Japan June Inflation Commentary: Impact on the Yen Exchange Rate
TradingKey - On 18 July 2025, Japan published its June inflation data, showing the headline Consumer Price Index (CPI) rising 3.3% year-on-year, a 0.2 percentage point drop from May’s figure.TradingKey
Mon, Jul 21
Apple FY2025 Q2 Earnings Preview: Can It Thrive in a Trade War Storm?
TradingKey - As Apple ready to release its Q2 FY2025 earnings, the tech giant stands at a crossroads, navigating a landscape shaped by robust fundamentals, escalating trade tensions, and intensifying competition. With its iconic brand and formidable cash flow, Apple remains a cornerstone of the...TradingKey
Tue, Apr 29
Tradingkey
